| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Yang,Hong-Ren | Chairman | 38.19% | SHAREHOPE MEDICINE CO., LTD. |
| Zhang,Si-Gang | Director | 38.19% | SHAREHOPE MEDICINE CO., LTD. |
| Wang,Hong-Jun | Director | 23.63% | FU BANG HEALTH MANAGEMENT CONSULTANT CO., LTD. |
| Zheng,Da | Director | 23.63% | FU BANG HEALTH MANAGEMENT CONSULTANT CO., LTD. |
| Zhong Hua,Kai-Fa-Er-Sheng-Yi-Chuang-Ye-Tou-Zi-You-Xian-He-Huo | Director | 26.92% | |
| Ye,Jing-Wen | Supervisor | 0.15% | |
| Cai,Zhi-Ming | Supervisor | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 |
|---|---|---|
| Operating income | 149,410 | 374,333 |
| Operating cost | 102,136 | 264,304 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - |
| Operating gross profit (loss) | 47,274 | 110,029 |
| Unrealized profit (loss) on sales of goods | - | - |
| Realized profit (loss) on sales of goods | - | - |
| Operating gross profit (loss), net | 47,274 | 110,029 |
| Operating expenses | 84,334 | 175,422 |
| Other gain (loss), net | 148 | 10,689 |
| Operating profit (loss) | -36,912 | -54,704 |
| Non-operating income and expenses | -5,577 | -10,854 |
| Net profit (loss) before tax | -42,489 | -65,558 |
| Income tax expense (benefits) | 510 | 1,698 |
| Net profit (loss) of ongoing business for the current period | -42,999 | -67,256 |
| Profit (loss) of closed units | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - |
| Net profit (loss) for the current period | -42,999 | -67,256 |
| Other comprehensive profit (loss), net | -1,602 | -2,932 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - |
| Total comprehensive profit and loss for the current period | -44,601 | -70,188 |
| Net profit (loss) attributable to owners of parent company | -42,999 | -68,269 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | 0 | 0 |
| Net profit (loss) attributable to non-controlling interests | 0 | 1,013 |
| Comprehensive profit (loss) attributable to owners of parent company | -44,601 | -71,201 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | 0 | 0 |
| Comprehensive profit (loss) attributable to non-controlling interests | 0 | 1,013 |
| Basic earnings per share (yuan) | -1 | -2 |
| 項目 | 2024 | 2023 |
|---|---|---|
| Net cash inflow (outflow) from operating activities | -17,428 | -47,297 |
| Net cash inflows (outflows) from investing activities | -3,194 | -146,146 |
| Net cash inflow (outflow) from financing activities | 7,491 | 82,132 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -13,131 | -111,311 |
| Beginning balance of cash and cash equivalents | 75,497 | 186,808 |
| Ending balance of cash and cash equivalents | 62,366 | 75,497 |
| 項目 | 2024 | 2023 |
|---|---|---|
| Current asset | 309,551 | 329,488 |
| Non-current asset | 501,258 | 540,446 |
| Total asset | 810,809 | 869,934 |
| Current liability | 483,199 | 465,235 |
| Non-current liability | 134,437 | 166,925 |
| Total liability | 617,636 | 632,160 |
| share capital | 269,919 | 269,919 |
| Equity - secruity token | - | - |
| capital reserve | 172,488 | 172,488 |
| retained earning | -226,732 | -183,733 |
| Other equity | -22,502 | -20,900 |
| Treasury stock | - | - |
| Total equity attributable to owners of parent company | 193,173 | 237,774 |
| Equity attributable to former owner of business combination under common control | 0 | 0 |
| Equity attributable to non-controlling interest before business merger under common control | - | - |
| Non-controlling interests | - | - |
| Total Equity | 193,173 | 237,774 |
| Share capital awaiting retirement (unit: share) | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 |
| Net asset value per share | 7 | 8 |
